AU2023901399A0 - Anti-SARS-CoV-2 antibodies and uses thereof - Google Patents

Anti-SARS-CoV-2 antibodies and uses thereof

Info

Publication number
AU2023901399A0
AU2023901399A0 AU2023901399A AU2023901399A AU2023901399A0 AU 2023901399 A0 AU2023901399 A0 AU 2023901399A0 AU 2023901399 A AU2023901399 A AU 2023901399A AU 2023901399 A AU2023901399 A AU 2023901399A AU 2023901399 A0 AU2023901399 A0 AU 2023901399A0
Authority
AU
Australia
Prior art keywords
cov
sars
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023901399A
Inventor
Steven ROCKMAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seqirus Pty Ltd
Original Assignee
Seqirus Pty Ltd
Filing date
Publication date
Application filed by Seqirus Pty Ltd filed Critical Seqirus Pty Ltd
Publication of AU2023901399A0 publication Critical patent/AU2023901399A0/en
Pending legal-status Critical Current

Links

AU2023901399A 2023-05-09 Anti-SARS-CoV-2 antibodies and uses thereof Pending AU2023901399A0 (en)

Publications (1)

Publication Number Publication Date
AU2023901399A0 true AU2023901399A0 (en) 2023-05-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP4010378A4 (en) Anti-ccr8 monoclonal antibodies and uses thereof
EP3918323A4 (en) Anti-gal3 antibodies and uses thereof
EP3901175A4 (en) Anti-cd73 monoclonal antibody and application thereof
EP3997127A4 (en) Dll3-targeting antibodies and uses thereof
EP4039708A4 (en) Anti-cll1 antibody and application thereof
EP3999545A4 (en) Anti-cd73 antibody and application thereof
EP3962954A4 (en) Anti-galectin-9 antibodies and uses thereof
EP4001308A4 (en) Anti-tigit antibodies and application thereof
EP4071172A4 (en) Anti-lilrb1 antibody and uses thereof
EP4025609A4 (en) Anti-steap1 antibodies and uses thereof
EP3992211A4 (en) Anti-cea antibody and application thereof
AU2022242135A1 (en) Anti-tau antibodies and uses thereof
TWI799855B (en) NOVEL MONOCLONAL ANTIBODIES AGAINST SARS-CoV-2 AND USES THEREOF
EP4010368A4 (en) Anti-nampt antibodies and uses thereof
EP4019544A4 (en) Antibody mutant and application thereof
AU2022298850A1 (en) Anti-ccr8 antibodies and uses thereof
EP3947462A4 (en) Anti-galectin-9 antibodies and uses thereof
EP4025611A4 (en) Anti-cxcr2 antibodies and uses thereof
EP3976659A4 (en) Anti-glypican-3 antibodies and uses thereof
AU2023901399A0 (en) Anti-SARS-CoV-2 antibodies and uses thereof
AU2023901335A0 (en) Anti-NPY-Y1 antibodies and uses thereof
AU2022901165A0 (en) Anti-NPY-Y1 antibodies and uses thereof
AU2023901400A0 (en) Anti-SARS-CoV-2 antibodies and uses thereof II
AU2023901403A0 (en) Anti-SARS-CoV-2 antibodies and uses thereof III
EP3927828A4 (en) Antibodies and enonomers